Results for tag: "Darbepoetin Alfa"

Darbepoetin Alfa is a type of hematological drug used to treat anemia. It is a recombinant form of erythropoietin, a hormone produced naturally in the body that stimulates the production of red blood cells. Darbepoetin alfa is used to treat anemia caused by chronic kidney disease, chemotherapy, or HIV/AIDS. It is also used to reduce the need for red blood cell transfusions in patients with certain types of anemia. The Darbepoetin Alfa market is highly competitive, with a number of companies offering products. Some of the major players in the market include Amgen, Pfizer, Johnson & Johnson, Novartis, and Roche. These companies are engaged in research and development activities to develop new products and expand their product portfolios. They are also investing in marketing and promotional activities to increase their market share. Show Less Read more